Six ACS Fellows Are Elected to the National Academy of Medicine

On October 19, the National Academy of Medicine (NAM) announced its newest class of members, including six ACS Fellows. Election recognizes distinguished contributions to health and medicine and a commitment to service. The Fellows were honored for achievements spanning cancer research, clinical care, health policy, and scientific discovery.

Marcela G. del Carmen, MD, MPH, FACS, a gynecologic oncologist, is president of Massachusetts General Hospital and the Massachusetts General Physician Organization and executive vice president of Mass General Brigham in Boston. NAM recognized her advances in ovarian and other gynecologic cancer care, alongside her leadership of a major academic institution’s clinical and educational missions.

William H. Frist, MD, FACS, a heart and lung transplant surgeon and former US Senate majority leader, is a founding partner of Frist Cressey Ventures in Nashville, Tennessee. He was honored for advancing US health reform, global health programs such as the President’s Emergency Plan for AIDS Relief, and NAM initiatives addressing climate and health.

Geoffrey C. Gurtner, MD, FACS, a plastic and reconstructive surgeon, is a professor and chair of the Department of Surgery at the University of Arizona College of Medicine–Tucson. His recognition highlights research translated into cleared medical devices and investigational drugs targeting diabetic amputations and scarring after burns and trauma.

Jacqueline S. Jeruss, MD, PhD, FACS, a breast surgical oncologist, is associate vice president for research–integrity and compliance at the University of Michigan in Ann Arbor and associate dean for regulatory affairs at its medical school. She was recognized for cancer research encompassing fertility preservation, molecular signaling, targeted treatments, and early metastasis detection, together with leadership in surgical education and research integrity. Dr. Jeruss’s research also was highlighted in a 2024 Bulletin feature.

Courtney A. Schreiber, MD, MPH, FACS, an obstetrician-gynecologist, is chief of the Division of Family Planning and Stuart and Emily B. H. Mudd Professor in Human Behavior and Reproduction at the University of Pennsylvania in Philadelphia. NAM honored her improvements to miscarriage treatment and early pregnancy services, reduction of unnecessary Rh testing, and leadership establishing complex family planning as a certified subspecialty.

Michael B. Yaffe, MD, PhD, FACS, a trauma surgeon and surgical oncologist, is the David H. Koch Professor of Science and director of the Center for Precision Cancer Medicine at the Massachusetts Institute of Technology in Cambridge. He also is an attending surgeon and intensivist at Beth Israel Deaconess Medical Center in Boston. He was recognized for discoveries explaining how proteins regulate cellular signaling, division, and stress responses, helping establish systems biology approaches to understanding these processes.